Search Results
Results found for "career development"
- GPCR Therapeutics Expands Scientific Advisory Board
Jon Wigginton will provide scientific expertise to support the company’s research and clinical development
- 📰 GPCR Weekly News, April 15 to 21, 2024
Hoare's workshop for individuals who live and work in developing countries. We define a developing country based on World Bank Classifications for its 2024 fiscal year.
- 📰 GPCR Weekly News, July 24 to July 30, 2023
GPCR Binders, Drugs, and more Development of a V5-tag-directed nanobody and its implementation as an Discovery Industry Indivior Announces Q2/H1 2023 Financial Results Scientists Discover a New Way To Develop
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
The research of GPCRs in the cochlea is essential for the understanding of the cochlea development, hearing
- Label-free LC-MS based assay to characterize small molecule compound binding to cells
Here we developed and validated a label-free, liquid chromatography-mass spectrometry (LC-MS) based cell
- Isoform-and ligand-specific modulation of adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder
- and ligand specific aGPCR functions using unique tools, and thus establishes a foundation for the development
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
pathological expression profile of GPR84 and, in the absence of direct structural information, recent developments
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
(Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation
- The microglial endocannabinoid system similarly regulated by lipopolysaccharide and interferon gamma
capacity of microglia to synthesize, degrade, and respond to cannabinoids which has implications for the development
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
The identification of unified innate threat pathways may provide insights into developing therapeutic
- Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease
Thus, increased SHH activity due to ciliary dysfunction may be required for the development of pathoetiological
- GPCR Happy Hour – Boston, Sept 2025
decades of experience, their services include AI-driven target identification, target validation, assay development
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Biological Keys to Medical Therapies From Structure to Solution: How Structural Biology Informs the Development Biologist GPCR Activation and Signaling Exploring Bias in GPCR Signaling and its Implication in Drug Development
- Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
(Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization
- Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical ...
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
pharmacological activity, allowing for the determination of drug kinetics—a critical aspect in drug development Some innovative solutions have been the development of the BERKY and the ONE-GO biosensors, designed
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
]i) signaling is a critical regulator of chondrogenesis, chondrocyte differentiation, and cartilage development a CNO dose- and frequency-dependent manner, and triggered the formation of cell condensations that developed
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development
- Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- Chemokine receptor-targeted drug discovery: progress and challenges
Drug discovery is shifting towards the development of biased ligands, which promote the engagement of differences in the chemokine systems between species which, in some cases, hampers the pre-clinical development
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
However, AlphaFold3 faces challenges with synthetic ligands, which are central to pharmaceutical development
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
We will discuss the historic context of pepducin development for each receptor, as well as the structural
- Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms
certain GPCR ligands can regulate GPCR/14-3-3 signals temporally, suggesting a new approach for GPCR drug development
- Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
treatment of many neurological conditions and several compounds targeting these receptors have been developed
- Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of...
It has begun to play important roles in drug development for complex diseases such as cancer, including
- VAMP2: a crucial player in the delivery of MOR to the synapse
Through developing a high-resolution method, Hao Chen et al. directly visualized the fusion of vesicles Therefore, their comprehension is essential for developing new treatments for these disorders and advancing




